No description available.

No description available.

Six new structural parameters £rB, £pB, £rC, £pC, £rS, and £pS are proposed to enhance the side chain actions in protein structures. Programs for calculating these new parameters based on phi and psi torsion angles vector algebra calculation method are established. A bivariate model with von Mises marginal distributions are applied to establish models of phi and psi in protein class Ophiophagus hannah neurotoxins and alpha-bungarotoxins respectively. 11 global structural parameters include phi and psi torsion angles, bond lengths of C-N, C-O, C£\ -C, and N-C£\, and bond angles of C-N-C£\, C£\-C-N, C£\-C-O, N-C£\-C, and O-C-N are considered to classify long alpha-neurotoxins by Ward's cluster method and LIBSVM program package. Those global structural parameters of loop II Trp residues of alpha-neurotoxins are discussed.

Les circuits neuronaux sous-tendant la locomotion requièrent d'intégrer à la fois des stimuli sensoriels et l'état physiologique. Cependant, la manière dont ces circuits fonctionnent pendant la locomotion active reste peu comprise. La larve de poisson zèbre est un organisme vertébré idéal pour étudier cette question de part son répertoire locomoteur simple et son accessibilité à la manipulation génétique. Dans le Chapitre 1, je décris le logiciel que nous avons développé afin de nous permettre de traquer les comportements et caractériser automatiquement les modules locomoteurs à haut débit. Les interneurones V2a sont des neurones excitateurs de la moelle épinière et du cerveau postérieur caractérisés par l'expression du facteur de transcription chx10. Afin de tester leur implication dans la locomotion, j'ai, dans le Chapitre 2, validé l'utilisation d'une toxine génétiquement encodée dans le but d'inhiber la population chx10 positive in vivo. Par analyse comportementale, enregistrements de locomotion fictive et imagerie calcique, nous avons montré que les V2as sont impliqués différemment dans la locomotion lente et rapide. Les neurones contactant le liquide céphalorachidien (NcLCRs) relaient des informations sensorielles aux circuits moteurs. Par ciblage génétique, imagerie calcique, pharmacologie et électrophysiologie, j'ai, dans le Chapitre 3, investigué le rôle de l'activité spontanée dans les NcLCRs. J'ai montré que l'ouverture de canaux PKD2L1 représentait une source intrinsèque d'activité spontanée dans les NcLCRs. Ces résultats offrent une meilleure compréhension de la manière dont les interactions dynamiques structurent les sorties locomotrices in vivo. / The neural networks that underlie locomotion are complex and require integration of sensory input and physiological state. However, how these networks function during active locomotion to incorporate sensory input from the environment and the internal state of the animal remains poorly understand. The zebrafish larva is an ideal vertebrate to study these questions thanks to its simple locomotor repertoire, transparency, and amenability to genetic manipulation. In Chapter 1, I describe a program to track behavior at high speeds and automatically characterize locomotor patterns in a high-throughput manner. V2a interneurons are excitatory interneurons in the spinal cord and hindbrain identified by the chx10 transcription factor. In Chapter 2, I validated the use of a genetically-encoded botulinum toxin to silence the chx10 population in vivo. Using fictive locomotor recordings and calcium imaging, I demonstrated that silencing V2as leads to decreased activity in primary motor neurons during fast swimming, corresponding to a lower swimming frequency in V2a-silenced larvae. Cerebrospinal fluid-contacting neurons (CSF-cNs) are intraspinal neurons that relay sensory information to motor circuits. CSF-cNs in diverse species express GABA and the transient receptor potential channel PKD2L1. In Chapter 3, I used genetic targeting, calcium imaging, pharmacology, and electrophysiology to investigate the role of spontaneous activity in CSF-cNs. I showed that single channel opening of PKD2L1 represents an intrinsic source of spontaneous activity in CSF-cNs. These tools and results will allow a more complete picture of how dynamic interactions shape locomotor output in vivo.

Trimethyltin (TMT) is known to produce substantial damage to the hippocampal formation. It also destroys neurons within the entorhinal cortex, thereby causing degeneration of perforant path afferents that terminate in the outer molecular layer (OML) of the dentate gyrus. Surgical destruction of the entorhinal cortex also causes the perforant path to degenerate. This leads to reactive synpatogenesis (axonal sprouting) of septal afferents to the dentate gyrus. The purpose of the present study was to determine whether administration of 6 mg/kg of TMT by gavage to rats would cause axonal sprouting within the septodentate projection. A histochemical stain for acetycholinesterase (AChE) was used. Compared to control subjects rats given TMT exhibited significantly denser AChE staining in the dentate OML. This is putative indication of reactive synaptogenesis within the cholinergic projection to this layer of the dentate and is somewhat surprising because other neurotoxins, such as lead and ethanol, that affect neurons within the hippocampal formation reduce the capacity for reactive synaptogenesis in response to lesions of the entorhinal cortex.

Degeneration of the noradrenergic neurons has been reported in the brain of patients suffering from neurodegenerative diseases. However, their pathological characteristics during the neurodegenerative course and underlying mechanisms remain to be elucidated. In the present study, we used the neurotoxin camptothecin (CPT) to induce the DNA damage response in neuroblastoma SH-SY5Y cells, normal fibroblast cells, and primarily cultured locus coeruleus (LC) and raphe neurons to examine cellular responses and repair capabilities after neurotoxin exposure. To our knowledge, the present study is the first to show that noradrenergic SH-SY5Y cells are more sensitive to CPT-induced DNA damage and deficient in DNA repair, as compared to fibroblast cells. Furthermore, similar to SH-SY5Y cells, primarily cultured LC neurons are more sensitive to CPT-induced DNA damage and show a deficiency in repairing this damage. Moreover, while N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) exposure also results in DNA damage in cultured LC neurons, neither CPT nor DSP4 induce DNA damage in neuronal cultures from the raphe nuclei. Taken together, noradrenergic SH-SY5Y cells and LC neurons are sensitive to CPT-induced DNA damage and exhibit a repair deficiency, providing a mechanistic explanation for the pathological characteristics of LC degeneration when facing endogenous and environmental DNA-damaging insults in vivo.

Dopamine β-hydroxylase (DBH) and norepinephrine (NE) transporter (NET) are the noradrenergic phenotypes for their functional importance to noradrenergic neurons. It is known that in vivo N-(2-chloroethyl)-N-ethyl-2- bromobenzylamine (DSP4) treatment induces degeneration of noradrenergic terminals by interacting with NET and depleting intracellular NE. However, DSP4's precise mechanism of action remains unclear. In this study various biochemical approaches were employed to test the hypothesis that DSP4 down-regulates the expression of DBH and NET, and to determine molecular mechanisms that may be involved. The results showed that treatment of SH-SY5Y neuroblastoma cells with DSP4 significantly decreased mRNA and protein levels of DBH and NET. DSP4-induced reduction of DBH mRNA and proteins, as well as NET proteins showed a time- and concentration-dependent manner. Flow cytometric analysis demonstrated that DSP4-treated cells were arrested predominantly in the S-phase, which was reversible. The arrest was confirmed by several DNA damage response markers (phosphorylation of H2AX and p53), suggesting that DSP4 causes replication stress which triggers cell cycle arrest via the S-phase checkpoints. Moreover, the comet assay verified that DSP4 induced single-strand DNA breaks. In summary, the present study demonstrated that DSP4 down-regulates the noradrenergic phenotypes, which may be mediated by its actions on DNA replication, leading to replication stress and cell cycle arrest. These action mechanisms of DSP4 may account for its degenerative consequence after systematic administration for animal models.

In the 1950s, the discovery of anti-nerve growth factor, an immunotoxin stunting sympathetic neural development, signaled the advent of neurotoxins as research modalities. Other selective neurotoxins were discovered in rapid succession. In the 1960s, 6-hydroxydopamine and 6-hydroxydopa were shown to destroy noradrenergic and dopaminergic nerves. Excitotoxins (glutamate, aspartate, and analogs) were discovered in the 1970s. DSP-4 [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] proved to be selective for noradrenergic destruction, while 5,6-and 5, 7-dihydroxytryptamines were relatively selective for serotonin neurons. Additional neurotoxins were discovered, but it was MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) that predominated neurotoxicity research in the 1980s. Eventually, Clostridium botulinum neurotoxin (BoNT), discovered as a "poisonous" principle in the late 1800s, resurfaced in purified and standardized forms as a clinically useful drug. Neurotoxins represent chemical tools, useful not only for discerning neuronal mechanisms and animal modeling of neurological disorders, but also for their use in medicine and potential as treatments for medical disorders. This unit reviews the early discovery of neurotoxins, describes categories of neurotoxins, and finally characterizes their usefulness - first as research tools, and eventually as clinical therapeutic agents.

Botulinum neurotoxin (BoNT), for more than a hundred years, has been a recognized poisonous principle in spoiled food. As its chemical structure became unraveled, and as more knowledge was gained over its mechanism of toxicity, it became clear that BoNT had the potential to act therapeutically as a targeted toxin that could inactivate specific nerve populations, and thus achieve a therapeutic goal. BoNT has evolved over the past 25 years into a viable therapeutic, now being a first line treatment for dystonia, overtly altering the course of progression of this disorder. BoNT is used for hyperhidrosis and gustatory sweating syndrome, alleviation of pain, as a treatment for overactive bladder, achalasia and anal fissure; and it has gained popularity as a cosmetic aid. Many other possible uses are being explored. The greatest potential for BoNT may lie in its being a molecular Trojan Horse - able to carry a specific enzyme or specific drug to the inside of a cancer or other type of cell while bypassing other cells and thereby having little or no ill effect. BoNTs pharmaceutical potential is boundless.

Botulinum Neurotoxin (BoNT) is one of the most potent toxins known to human kind. The Atomic Force Microscope (AFM) was employed to investigate the conditions under which BoNT type A heavy chain would bind and/or insert into mica supported dipalmitoylphosphatidylcholine (DPPC) lipid bilayers. As an alternate technique, DPPC/GT1b or total ganglioside extract (80:20) monolayers of a Langmuir Blodgett (LB) Trough were adapted to be artificial membrane models for toxin insertion studies. We conclude that LB monolayer studies are a promising candidate for BoNT/A membrane insertion investigation. Botulinum neurotoxin serotype A insertions into the LB monolayers in the presence of BoNT/A low affinity ganglioside receptor alone, independent of pH. This thermodynamic evidence indicates that BoNT/A may begin its heavy chain insertion into the cholinergic nerve ending before endocytosis and acidification.